What FDA Failed to Disclose 1991, 2006 Vera Hassner Sharav Alliance for Human Research Protection.
Prognostic Utility of Secretory Phospholipase A 2 in Patients with Stable Coronary Artery Disease M. O'Donoghue, Z. Mallat, D.A. Morrow, J. Benessiano,
1 ATRIAL FIBRILLATION AT BASELINE AND DURING FOLLOW-UP in The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial November 9, 2003.
Jean Yoon December 15, 2010 Research Design. Outline Causality and study design Quasi-experimental methods for observational studies –Covariate matching.
Tweaking - khb - to control for post-treatment confounders in mediation analysis
1 Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin The WHI Investigators.
ALLHAT
Q.A. Truong et al. Circ Cardiovasc Qual Outcomes 2011;4:328-336
Response, PFS or OS – what is the best endpoint in advanced colorectal cancer? Marc Buyse
Introduction to Design of Genomic Clinical Trials
Support establishment of National Fund for SME Development [Kuwait] Istanbul, May 14, 2015.
How to design a study
![Support establishment of National Fund for SME Development [Kuwait] Istanbul, May 14, 2015.](https://static.fdocuments.in/doc/330x215/56649dd45503460f94acc52b/support-establishment-of-national-fund-for-sme-development-kuwait-istanbul.jpg)
